MindBio Therapeutics Develops AI-Powered Voice Analysis for Non-Invasive Drug and Alcohol Detection

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is addressing the growing need for non-invasive intoxication detection with its AI-powered voice analysis technology. The platform analyzes more than 140 acoustic markers and has been trained on a dataset exceeding 50 million data points to detect drug and alcohol impairment from short speech samples.

Workplace impairment testing remains an essential component of risk management across many industries, but the methods used today have changed relatively little over the past several decades. Employers continue to rely heavily on breathalyzers, saliva tests, urine screening and laboratory analysis to identify alcohol and drug impairment. While effective, these methods can be expensive, time-consuming and difficult to scale across large workforces. That challenge is becoming increasingly relevant as regulators and employers place greater emphasis on workplace safety, compliance and operational efficiency.

Against this backdrop, MindBio Therapeutics is developing a technology platform that takes a different approach. The company has spent several years conducting drug and alcohol research while building artificial intelligence and machine-learning capabilities. Mining operations in South America represent the company’s initial commercial focus, where workforce safety and high-volume screening requirements create operational challenges. Potential applications extend beyond mining into aviation, construction, law enforcement, call centers, transportation, and mental health settings.

The global alcohol and drug testing devices market is projected to grow from approximately $2.5 billion in 2025 to $4.2 billion by 2033. MindBio’s approach seeks to provide a faster, less invasive alternative to traditional breath, saliva, urine and laboratory-based testing methods. By leveraging voice analysis, the company aims to enable rapid, scalable screening that can be conducted remotely or on-site without the need for specialized equipment or sample collection.

For more information, visit the company’s newsroom at https://nnw.fm/MBQIF.